| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | BRD-K04800985 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.1 |